Gaxos.ai (NASDAQ: GXAI) stock soared over 50% on Wednesday after it secured AI-enabled technology rights from a leading biohacking app.
Gaxos.ai (GXAI) has just announced its acquisition of the rights to incorporate AI-enabled technology from the renowned biohacking app, “Ultiself.” This move aims to facilitate the development of its technological capabilities for Gaxos Health.
The company plans to incorporate the Ultiself technology into its upcoming product lineup to improve customization and user experience.
Vadim Mats, CEO of Gaxos.ai, said,
“By securing the rights to use this tech, we will be able to accelerate the development of our AI-enabled application for the Gaxos Health product offering.”
Mats added,
“This tech is intended to allow us to offer a more customized approach to delivering customers diet, nutrition, and tracking capabilities.”
On February 28, Gaxos.ai revealed the formation of a Medical Advisory Board to bolster the launch of its AI-powered Health and Wellness solution. Dr. Nate Lebowitz, M.D., has been named Chairman of the Advisory Board.
On February 16, Gaxos.ai revealed plans for its gaming division, Gaxos Gaming, to introduce an AI solution tailored for game developers and studios.
Gaxos.ai (NASDAQ: GXAI) Stock Reaction
GXAI stock shot up 51.13% to close at $8.04 on Monday. The traders had exchanged hands with 43,418,090 (43.41 million) shares compared to the average daily trading volume of 242.33K.
